Related Experiment Video
Updated: Jul 18, 2026
07:54
Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Hypertension research in sleep apnea
Trent A Hargens1, Sharon M Nickols-Richardson, John M Gregg
1Department of Human Nutrition, Foods and Exercise, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA. tahargens@bsu.edu
Journal of Clinical Hypertension (Greenwich, Conn.)
|December 16, 2006
Summary
Obstructive sleep apnea (OSA) significantly elevates hypertension risk, primarily through sympathetic nervous system activation. Standard OSA therapy and lifestyle changes can help manage blood pressure in affected individuals.
Area of Science:
- Cardiology
- Sleep Medicine
- Hypertension Research
Background:
- Obstructive sleep apnea (OSA) affects up to 20% of adults, frequently co-occurring with obesity.
- OSA involves repetitive upper airway collapse during sleep, leading to stress arousals and impaired breathing.
- Strong evidence links OSA to increased risks of hypertension and cardiovascular events, with sympathetic overactivation as a key mechanism.
Purpose of the Study:
- To review current data on OSA's impact on blood pressure.
- To evaluate the effectiveness of standard OSA treatments on blood pressure control.
- To explore lifestyle modifications for reducing hypertension risk in OSA patients.
Main Methods:
- Literature review of recent studies on OSA and blood pressure.
- Analysis of data concerning standard OSA therapies (e.g., CPAP) and their effects.
- Examination of research on lifestyle interventions (e.g., weight loss) for hypertension in OSA.
Main Results:
- OSA is a significant contributor to elevated blood pressure and cardiovascular morbidity.
- Sympathetic nervous system activation is a primary mediator linking OSA to hypertension.
- Standard OSA treatments show potential for improving blood pressure, but challenges remain in outcome assessment.
Conclusions:
- OSA is a critical factor in hypertension development and management.
- Therapeutic strategies for OSA, including lifestyle changes, are essential for cardiovascular risk reduction.
- Further research is needed to overcome challenges in evaluating treatment efficacy for blood pressure in OSA patients.
Related Concept Videos
01:21Sleep Apnea
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...